Methanolic extract of Tamarix Gallica attenuates hyperhomocysteinemia induced AD-like pathology and cognitive impairments in rats
暂无分享,去创建一个
Jian-Zhi Wang | Xiaochuan Wang | Bin Zhang | Qun Wang | Feiqi Zhu | Dan Ke | Rong Liu | Zhendong Xu | Y. Mahaman | Yuman Wang | F. Huang | Maibouge Tanko Mahamane Salissou
[1] N. Tyagi,et al. High methionine, low folate and low vitamin B6/B12 (HM-LF-LV) diet causes neurodegeneration and subsequent short-term memory loss , 2018, Metabolic brain disease.
[2] M. Adamkov,et al. Association of Induced Hyperhomocysteinemia with Alzheimer’s Disease-Like Neurodegeneration in Rat Cortical Neurons After Global Ischemia-Reperfusion Injury , 2018, Neurochemical Research.
[3] E. D. Kirby,et al. A Larger Social Network Enhances Novel Object Location Memory and Reduces Hippocampal Microgliosis in Aged Mice , 2018, Front. Aging Neurosci..
[4] Jian-Zhi Wang,et al. Moringa Oleifera Alleviates Homocysteine-Induced Alzheimer’s Disease-Like Pathology and Cognitive Impairments , 2018, Journal of Alzheimer's disease : JAD.
[5] S. Haggarty,et al. Inhibition of p25/Cdk5 Attenuates Tauopathy in Mouse and iPSC Models of Frontotemporal Dementia , 2017, The Journal of Neuroscience.
[6] Guowei Huang,et al. Homocysteine exaggerates microglia activation and neuroinflammation through microglia localized STAT3 overactivation following ischemic stroke , 2017, Journal of Neuroinflammation.
[7] H. Isoda,et al. Inhibitory Activities of Antioxidant Flavonoids from Tamarix gallica on Amyloid Aggregation Related to Alzheimer's and Type 2 Diabetes Diseases. , 2017, Biological & pharmaceutical bulletin.
[8] Shengdi Chen,et al. Oxidative stress: A major pathogenesis and potential therapeutic target of antioxidative agents in Parkinson’s disease and Alzheimer’s disease , 2016, Progress in Neurobiology.
[9] S. Antonov,et al. GluN2A Subunit-Containing NMDA Receptors Are the Preferential Neuronal Targets of Homocysteine , 2016, Front. Cell. Neurosci..
[10] Jingwei Tian,et al. (-)-SCR1693 Protects against Memory Impairment and Hippocampal Damage in a Chronic Cerebral Hypoperfusion Rat Model , 2016, Scientific Reports.
[11] L. Luo,et al. A novel acetylcholinesterase inhibitor and calcium channel blocker SCR-1693 improves Aβ25–35-impaired mouse cognitive function , 2016, Psychopharmacology.
[12] K. Mccully. Homocysteine Metabolism, Atherosclerosis, and Diseases of Aging. , 2015, Comprehensive Physiology.
[13] N. Inestrosa,et al. Is L-methionine a trigger factor for Alzheimer’s-like neurodegeneration?: Changes in Aβ oligomers, tau phosphorylation, synaptic proteins, Wnt signaling and behavioral impairment in wild-type mice , 2015, Molecular Neurodegeneration.
[14] Anupom Borah,et al. Activation of NMDA receptor by elevated homocysteine in chronic liver disease contributes to encephalopathy. , 2015, Medical hypotheses.
[15] Q. Tian,et al. A novel tacrine-dihydropyridine hybrid (-)SCR1693 induces tau dephosphorylation and inhibits Aβ generation in cells. , 2015, European journal of pharmacology.
[16] K. Ishiguro,et al. Physiological and pathological phosphorylation of tau by Cdk5 , 2014, Front. Mol. Neurosci..
[17] S. Merali,et al. Homocysteine exacerbates β‐amyloid pathology, tau pathology, and cognitive deficit in a mouse model of Alzheimer disease with plaques and tangles , 2014, Annals of neurology.
[18] D. Fayuk,et al. The role of NMDA and mGluR5 receptors in calcium mobilization and neurotoxicity of homocysteine in trigeminal and cortical neurons and glial cells , 2014, Journal of neurochemistry.
[19] Xiongwei Zhu,et al. Phosphorylation of Tau Protein as the Link between Oxidative Stress, Mitochondrial Dysfunction, and Connectivity Failure: Implications for Alzheimer's Disease , 2013, Oxidative medicine and cellular longevity.
[20] Jian-Zhi Wang,et al. Cleavage of GSK‐3β by calpain counteracts the inhibitory effect of Ser9 phosphorylation on GSK‐3β activity induced by H2O2 , 2013, Journal of Neurochemistry.
[21] C. Abdelly,et al. Anticancer effect of Tamarix gallica extracts on human colon cancer cells involves Erk1/2 and p38 action on G2/M cell cycle arrest , 2013, Cytotechnology.
[22] H. Isoda,et al. Inhibition of Amyloid β Aggregation by Acteoside, a Phenylethanoid Glycoside , 2013, Bioscience, biotechnology, and biochemistry.
[23] K. Irie,et al. Site-specific Inhibitory Mechanism for Amyloid β42 Aggregation by Catechol-type Flavonoids Targeting the Lys Residues* , 2013, Journal of Biological Chemistry.
[24] Charles D. Smith,et al. Induction of Hyperhomocysteinemia Models Vascular Dementia by Induction of Cerebral Microhemorrhages and Neuroinflammation , 2013, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.
[25] M. Sharma,et al. Antioxidant Activity, Total Phenolic, And Flavonoid Content Of Aerial Parts Of Tamarix Gallica , 2012 .
[26] F. Checler,et al. BACE1 is at the crossroad of a toxic vicious cycle involving cellular stress and β-amyloid production in Alzheimer’s disease , 2012, Molecular Neurodegeneration.
[27] H. Isoda,et al. Protective effects of caffeoylquinic acids on the aggregation and neurotoxicity of the 42-residue amyloid β-protein. , 2012, Bioorganic & Medicinal Chemistry.
[28] J. Drazen. Transparency for clinical trials--the TEST Act. , 2012, The New England journal of medicine.
[29] N. Greig,et al. TNF-α protein synthesis inhibitor restores neuronal function and reverses cognitive deficits induced by chronic neuroinflammation , 2012, Journal of Neuroinflammation.
[30] F. LaFerla,et al. Blocking IL-1 Signaling Rescues Cognition, Attenuates Tau Pathology, and Restores Neuronal β-Catenin Pathway Function in an Alzheimer’s Disease Model , 2011, The Journal of Immunology.
[31] L. Tsai,et al. Synaptic Deficits Are Rescued in the p25/Cdk5 Model of Neurodegeneration by the Reduction of β-Secretase (BACE1) , 2011, Journal of Neuroscience.
[32] Richard E. White,et al. The role of N-methyl-D-aspartate receptor activation in homocysteine-induced death of retinal ganglion cells. , 2011, Investigative ophthalmology & visual science.
[33] R. Mayeux,et al. Epidemiology of Alzheimer disease , 2011, Nature Reviews Neurology.
[34] Richard Mooney,et al. Rapid spine stabilization and synaptic enhancement at the onset of behavioural learning , 2010, Nature.
[35] W. Gordon-Krajcer,et al. Homocysteine-induced acute excitotoxicity in cerebellar granule cells in vitro is accompanied by PP2A-mediated dephosphorylation of tau , 2009, Neurochemistry International.
[36] Jia-min Zhuo,et al. Diet-induced hyperhomocysteinemia increases amyloid-beta formation and deposition in a mouse model of Alzheimer's disease. , 2009, Current Alzheimer research.
[37] C. Abdelly,et al. Antioxidant and antimicrobial activities of the edible medicinal halophyte Tamarix gallica L. and related polyphenolic constituents. , 2009, Food and chemical toxicology : an international journal published for the British Industrial Biological Research Association.
[38] Surojit Paul,et al. Homocysteine–NMDA receptor‐mediated activation of extracellular signal‐regulated kinase leads to neuronal cell death , 2009, Journal of neurochemistry.
[39] B. Ossola,et al. The multiple faces of quercetin in neuroprotection , 2009, Expert opinion on drug safety.
[40] Q. Tian,et al. Hyperhomocysteinemia increases beta-amyloid by enhancing expression of gamma-secretase and phosphorylation of amyloid precursor protein in rat brain. , 2009, The American journal of pathology.
[41] E. Head. Oxidative Damage and Cognitive Dysfunction: Antioxidant Treatments to Promote Healthy Brain Aging , 2009, Neurochemical Research.
[42] Hangyuan Guo,et al. Influence of folic acid on plasma homocysteine levels & arterial endothelial function in patients with unstable angina. , 2009, The Indian journal of medical research.
[43] Ahmed Bensatal,et al. Inhibition of crystallization of calcium oxalate by the extraction of Tamarix gallica L , 2008, Urological Research.
[44] S. Bischoff. Quercetin: potentials in the prevention and therapy of disease , 2008, Current opinion in clinical nutrition and metabolic care.
[45] V. Lučić,et al. Detailed state model of CaMKII activation and autophosphorylation , 2008, European Biophysics Journal.
[46] R. V. van Marum,et al. Current and future therapy in Alzheimer’s disease , 2008, Fundamental & clinical pharmacology.
[47] I. Grundke‐Iqbal,et al. Kinases and phosphatases and tau sites involved in Alzheimer neurofibrillary degeneration , 2007, The European journal of neuroscience.
[48] M. Pappolla,et al. Hyperhomocysteinemic Alzheimer's mouse model of amyloidosis shows increased brain amyloid β peptide levels , 2006, Neurobiology of Disease.
[49] S. Sultana,et al. Tamarix gallica ameliorates thioacetamide–induced hepatic oxidative stress and hyperproliferative response in Wistar rats , 2006, Journal of enzyme inhibition and medicinal chemistry.
[50] Ehud Gazit,et al. Inhibition of Amyloid Fibril Formation by Polyphenols: Structural Similarity and Aromatic Interactions as a Common Inhibition Mechanism , 2006, Chemical biology & drug design.
[51] K. Ashe,et al. Age-Dependent Neurofibrillary Tangle Formation, Neuron Loss, and Memory Impairment in a Mouse Model of Human Tauopathy (P301L) , 2005, The Journal of Neuroscience.
[52] F. D’Anselmi,et al. S-adenosylmethionine/homocysteine cycle alterations modify DNA methylation status with consequent deregulation of PS1 and BACE and beta-amyloid production , 2005, Molecular and Cellular Neuroscience.
[53] N. D. De Santo,et al. Homocysteine and oxidative stress , 2003, Amino Acids.
[54] R. Liu,et al. Inhibition of protein phosphatase 2A- and protein phosphatase 1-induced tau hyperphosphorylation and impairment of spatial memory retention in rats , 2003, Neuroscience.
[55] G. Perry,et al. Oxidative Stress Increases Expression and Activity of BACE in NT2 Neurons , 2002, Neurobiology of Disease.
[56] E. Itarte,et al. PP1/PP2A phosphatases inhibitors okadaic acid and calyculin A block ERK5 activation by growth factors and oxidative stress , 2002, FEBS letters.
[57] D. Butterfield,et al. Lipid peroxidation and protein oxidation in Alzheimer's disease brain: Potential causes and consequences involving amyloid β-peptide-associated free radical oxidative stress , 2002 .
[58] W. Kisiel,et al. Hyperhomocysteinemia enhances vascular inflammation and accelerates atherosclerosis in a murine model. , 2001, The Journal of clinical investigation.
[59] D. Campion,et al. The pathogenic L392V mutation of presenilin 1 decreases the affinity to glycogen synthase kinase-3β , 2000, Neuroscience Letters.
[60] R Clarke,et al. Folate, vitamin B12, and serum total homocysteine levels in confirmed Alzheimer disease. , 1998, Archives of neurology.
[61] K. Imahori,et al. Characterization of tau phosphorylation in glycogen synthase kinase-3beta and cyclin dependent kinase-5 activator (p23) transfected cells. , 1998, Biochimica et biophysica acta.
[62] I. Grundke‐Iqbal,et al. Restoration of biological activity of Alzheimer abnormally phosphorylated tau by dephosphorylation with protein phosphatase-2A, -2B and -1. , 1996, Brain research. Molecular brain research.
[63] F Benfenati,et al. Synaptic vesicle phosphoproteins and regulation of synaptic function. , 1993, Science.
[64] M. Khalid,et al. Tamarix gallica : For traditional uses , phytochemical and pharmacological potentials , 2016 .
[65] C. H. T. de Paula da Silva,et al. Alzheimer's disease: A review from the pathophysiology to diagnosis, new perspectives for pharmacological treatment. , 2016, Current medicinal chemistry.
[66] Liang Shen,et al. Associations between Homocysteine, Folic Acid, Vitamin B12 and Alzheimer's Disease: Insights from Meta-Analyses. , 2015, Journal of Alzheimer's disease : JAD.
[67] Q. Tian,et al. Novel multipotent AChEI-CCB attenuates hyperhomocysteinemia-induced memory deficits and Neuropathologies in rats. , 2014, Journal of Alzheimer's disease : JAD.
[68] Swatantra Bahadur Singh,et al. Phytochemical Screening and Physicochemical Parameters of Crude Drugs : A Brief Review , 2014 .
[69] Z. A. Oztürk,et al. Altered levels of homocysteine and serum natural antioxidants links oxidative damage to Alzheimer's disease. , 2013, Journal of Alzheimer's disease : JAD.
[70] G. Russo,et al. The flavonoid quercetin in disease prevention and therapy: facts and fancies. , 2012, Biochemical pharmacology.
[71] M. Sharma,et al. ANTI- INFLAMMATORY AND ANALGESIC ACTIVITY OF TAMARIX GALLICA , 2012 .
[72] R. Nitrini,et al. Peripheral oxidative stress biomarkers in mild cognitive impairment and Alzheimer's disease. , 2011, Journal of Alzheimer's disease : JAD.
[73] R. von Bernhardi. Glial cell dysregulation: a new perspective on Alzheimer disease. , 2007, Neurotoxicity research.
[74] Peter Johnson,et al. Homocysteine and its derivatives as possible modulators of neuronal and non-neuronal cell glutamate receptors in Alzheimer's disease. , 2007, Journal of Alzheimer's disease : JAD.
[75] S. Seshadri. Elevated plasma homocysteine levels: risk factor or risk marker for the development of dementia and Alzheimer's disease? , 2006, Journal of Alzheimer's disease : JAD.
[76] R. Friedland,et al. Plasma total homocysteine levels, dietary vitamin B6 and folate intake in AD and healthy aging. , 2003, The journal of nutrition, health & aging.